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EDITORIAL 
 
Predicting survival after surgery: a matter of life and death 
 
The quantification of risk is now embedded in our approach to the assessment of the high-risk surgical patient, 
although this has not always been the case. The past fifty years have seen a dramatic change in approach [1]. In 
1957, Dripps and colleagues suggested that the quantification of peri-operative risk was not possible, due to the 
myriad factors involved [2]. Ten years later, the 1967 edition of the American College of Surgeons publication 
Manual of Preoperative and Postoperative Management distinguished between good-, intermediate- and poor-
risk patients [3]. The 1977 publication of the Goldman cardiovascular risk scoring system [4] ushered in the 
approach whereby a number of factors are selected using statistical methods and combined to give a quantitative 
estimate of peri-operative risk. The publication of the Cardiac Risk Index marked a move to a probabilistic 
approach that sought to quantify risk but acknowledged that the outcome for an individual patient could not be 
predicted with certainty. In their review of the changes in approach to the definition of surgical risk, Neuman and 
Bosk report that by 1987, the Goldman Risk Index had been cited 224 times [1]. The decades since have seen the 
development of a substantial body of work based on this approach, with the development of general risk 
prediction tools such as the Lee Cardiovascular Risk Score, the POSSUM score and surgery-specific tools such as 
the Glasgow Aneurysm Score [5-7]. All of these focus on the risk of complications or mortality in the immediate 
postoperative period. In this edition of Anaesthesia, Carlisle and colleagues present a validation study of a clinical 
risk prediction tool that predicts not the likelihood of major complications and death, ďƵƚƚŚĞƉĂƚŝĞŶƚ ?ƐĐŚĂŶĐĞƐŽĨ
survival based on data from four centres on patients undergoing aortic surgery [8]. 
Carlisle has previously drawn attention to the fact that patients ? concerns about outcome extend  ?beyond 
one lunar orbit ? ?Ɖeople do not undergo elective surgery in order to gain only an additional 30 days of life but to 
improve their long-term survival and wellbeing [9]. He has constructed a clinical risk prediction tool that takes an 
actuarial approach based on the UK Office for National Statistics (ONS) Life Tables. For a person of a given age and 
sex, the ONS tables give an estimate of mortality rate and life expectancy. The tool produced by Carlisle modifies 
this estimate to take in to account the presence of various clinical risk factors, renal function, and the ƉĂƚŝĞŶƚ ?Ɛ 
exercise capacity. The tool provides an estimate of the likelihood of death with and without surgery, both in the 
next month and for longer periods. The model allows an estimate to be made of the extent to which an operation 
ŵĂǇƐŚŽƌƚĞŶŽƌůĞŶŐƚŚĞŶƚŚĞƉĂƚŝĞŶƚ ?Ɛlife. Thus, it is potentially able to inform care more than tools that offer 
only an estimate of the percentage of patients who will suffer morbidity or mortality following surgery. 
The study of outcome from aortic aneurysm repair is particularly apposite, since this is a prophylactic 
procedure done not to cure a disease such as cancer but to prevent aneurysm rupture. The patient will not be 
better immediately after surgery and may be considerably worse. Clinical decision-making is rendered more 
complex by the fact that there is more than one surgical option, and patients may be offered either open or 
endovascular repair, which have differing short- and long-term risk profiles. Therefore, questions of long-term 
survival with and without intervention are thrown into sharp relief. 
This risk calculator presents a new paradigm for balancing the risks and benefits of surgery, and raises 
questions over the role of exercise testing in pre-operative risk assessment, the appropriateness of modifying 
lifetable mortality estimates with data from other risk tools, and the process by which the model was 
constructed. These will be considered below. 
Cardiopulmonary exercise testing (CPET) has become established as a component of risk stratification 
before aortic aneurysm surgery in many centres. There is a body of evidence to support an association between 
estimates of functional capacity derived from CPET and complications following aortic surgery [10-18]. The work 
of Barakat et al. published in this issue of Anaesthesia adds to this evidence by demonstrating associations 
between a decreased anaerobic threshold and cardiac complications and between increased ventilatory 
equivalents for carbon dioxide and pulmonary complications.  However, studies supporting the use of CPET are 
relatively small, generally including only a few hundred patients, and most were not blinded. A systematic review 
published in 2012 made the point that there is variation between studies both in the variables chosen to quantify 
functional capacity (generally anaerobic threshold or peak ሶO2) and in the cut-off values used to classify patients 
[19]. These issues remain unresolved. One group has suggested an approach based on the number of variables 
outside of the normal range [12]. It is also important to question whether knowledge of the results of a CPET test 
improve risk stratification after the impact of clinical risk factors, such as a history of ischaemic heart disease or 
renal impairment, has been taken into account. Studies that include multivariate analyses of the impact of both 
CPET-derived variables and other risk factors have yielded inconsistent results [12, 16, 17]. Although, strictly 
speaking, the model of Carlisle et al. predicts survival rather than the risk of complications, it includes multivariate 
analyses of multiple risk factors and supports the evidence that data from CPET contributes to pre-operative risk 
stratification [9]. Questions remain as to which CPET variables and cut-off values should be used for risk 
assessment and the added value offered by CPET when other risk factors are taken into account. 
This predictive model uses CPET-derived variables to model predicted life expectancy, rather than the risk 
of complications, and is based on work that demonstrates an association between functional capacity and life 
expectancy [20]. Although such studies involve many hundreds of patients, they were not conducted in surgical 
populations and possible geographic variability is not taken into account. Correction for functional capacity is 
made after adjustments have been applied for cardiovascular risk factors. Since the effects of cardiovascular 
disease may be reflected in reduced functional capacity, it is possible that the approach adopted by Carlisle et al. 
includes a double adjustment for the effect of cardiovascular disease. 
The inclusion of clinical risk factors, such as a history of heart failure or previous myocardial infarction, in 
the model will make intuitive sense to all who are familiar with the approach taken to modelling the risk of peri-
operative risk complications in tools such as the Revised Cardiac Risk Index [6]. The inclusion in the model of a 
history of renal dysfunction, stroke, heart failure and myocardial infarction reflects the findings of studies of the 
risk of cardiovascular disease and death. For example, these risk factors appear in an analysis of predictors of 
death, myocardial infarction and disabling stroke using data from the ACTION trial, one of several references cited 
[21]. However, it is not clear how the weights given to thĞƐĞǀĂƌŝĂďůĞƐŝŶĂƌůŝƐůĞ ?ƐŵŽĚĞů ?ŝŶĐƌĞĂƐŝŶŐŵŽƌƚĂůŝƚǇ
hazard by 1.5 times in each case) are derived. The hazard ratios for the risk of death attributable to previous 
myocardial infraction and to stroke in the analysis of the data from ACTION are 1.15 and 1.7 respectively. It is also 
not clear why factors such as smoking and diabetes are excluded from the Carlisle model. 
Overall, the approach taken to the construction of the model is plausible but cannot automatically be 
assumed to be valid. Despite this, ĂƌůŝƐůĞĞƚĂů ? ?Ɛstudy suggests that the model yields valid results in an external 
population of patients [8]. There are some constraints. It is not clear if data from patients in the Torbay dataset 
used in the validation study had also been used in the derivation of the model, and complete data were not 
available from all centres. There was significant variation between centres; in particular, there appeared to be a 
systematic difference in the results of CPET tests from one centre. 
Neither the model proposed by Carlisle et al., nor other currently available risk prediction tools, can fully 
inform the discussion with the patient of the risks and benefits of surgery. Health-related quality of life declines 
after both open and endovascular aortic aneurysm repair [22] but generally recovers over the next 6-12 months, 
although a proportion of patients experience long-term reduction in health-related quality of life. In such cases, 
the patient might regret accepting surgery, especially if the risks of aneurysm rupture were modest. The Carlisle 
model is based on the likelihood of survival with and without surgery and does not purport to predict the 
likelihood of postoperative complications, nor offer information on the likely impact of surgery on quality of life. 
Research on the prediction of quality-of-life outcomes after surgery is challenging but is sorely needed. 
Concepts such as of the risk of complications following surgery or the impact of medical interventions on 
life expectancy can be difficult to explain to patients not used to thinking in probabilistic terms. A recent editorial 
in this journal has explored these challenges and the use of concepts such as micromorts and mircolives to 
translate abstract mathematical descriptions of risk into concrete estimates of change in life expectancy [23]. 
Even the best mathematical models cannot provide all the information necessary to inform a decision to undergo 
surgery. Patients do not consider the offer of surgery in purely probabilistic or mathematical terms, and may 
make choices that are mathematically nonsensical but entirely appropriate in human terms. Taking an example 
from obstetrics, mathematical modelling suggests that a trial of labour is the most appropriate strategy for 
mothers who have undergone previous caesarean section, because of the low risk to the mother and the high 
rate of successful vaginal delivery. However, when offered a choice, mothers heavily favoured repeat caesarean 
section, as they prioritised avoiding even very low risks to the infant [24]. Similarly, whilst a mathematical 
consideration of risk may indicate it is better not to intervene on a small aneurysm in an elderly patient, many 
patients and surgeons find inaction challenging. All clinicians who regularly attend a vascular multidisciplinary 
team meeting will be familiar with the dilemma of the how best to serve the interests of the high-risk patient 
who, despite advice that the risks outweigh the benefits, are adamant that they want an operation because 
anxiety about possible aortic rupture is destroying their quality of life. It is notable that in the EVAR2 trial of 
endovascular repair versus best medical therapy in high-risk patients with abdominal aortic aneurysms, there was 
a significant crossover in the group of patients randomised to best medical care, with a quarter of such patients 
undergoing aneurysm repair [25]. 
In a second paper published in this journal Carlisle applies the model underling the risk calculator to simulate 
survival in AAA patients with aneurysms ranging from 45-85 mm in diameter and with a spectrum of hazard of 
death from any cause at presentation ranging from 0.5 to 2% per month. These simulations suggest that there is 
significant benefit in offering early aneurysm repair to a low risk patient with an aneurysm 45 mm in diameter. 
There seems to be little benefit in offering AAA repair to some higher risk patients even when they present with 
an aneurysm that is significantly greater than 55 mm in diameter.  In many such cases intervention may shorten 
rather than lengthen life.  These conclusions rest on the reliability of the risk model.  If valid the inevitable 
conclusion is that the current approach of taking 55 mm as the diameter that should trigger considering of AAA 
repair in men requires re-examination.  The studies upon which this is based are now more than 20 years old and 
much has changed in the interim.  As Carlisle himself points out, life expectancy has increased over this period so 
that the potential benefits of appropriate AAA management are significantly greater.   
To summarise, the approach to modelling survival presented by Carlisle et al. is unorthodox. The 
modelling process is not clear and no explanation is given as to why particular values were selected for the 
coefficients in the model. The model describes only survival and gives no information about the likelihood of 
complications. It is, however, pragmatic and has face validity, and its construction reflects clinical thinking about 
peri-operative risk and outcome. ĂƌůŝƐůĞĞƚĂů ? ?Ɛvalidation study suggests that the model ?ƐƉƌĞĚŝĐƚions are 
consistent with clinical outcomes but further studies are required. Studies of the model nested within data 
collection for national surgical registries, such as the National Vascular Registry, could be attempted. If these also 
validate the tool, it should then be tested in a randomised controlled trial, although the logistics will be 
challenging. However, by modelling survival rather than the risk of complications, the model offers a valuable and 
insightful alternative approach to assessing the risks and benefits of surgery. If widely implemented, it would 
represent a paradigm shift just as great as that wrought by the introduction of the Goldman Cardiac Risk Index. 
Such a change should rest on a rigorous and robust evidence base. 
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